Mycobacterium tuberculosis in Taiwan

Po Ren Hsueh, Yung Ching Liu, Jen So, Cheng Yi Liu, Pan Chyr Yang, Kwen Tay Luh

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

Objective: The resurgence of tuberculosis (TB) and the emergence of drug resistance of Mycobacterium tuberculosis (MTB) isolates are of great impact on public health. Methods: Taiwanese data on disease burden of TB and anti-microbial resistance of MTB identified from Annual Reports of Centre for Disease Control, Department of Health, Taiwan and from peer-reviewed publications from MEDLINE (1995-2004). Results: In Taiwan in 2002, the incidence (per 100 000 population) of tuberculosis was 74.6 and it was higher in aborigines (289.8) and in people living in mountainous regions (256.0). The mortality rate of tuberculosis in Taiwan in 2002 was 5.68 per 100 000 population. Susceptibility data summarized from 1990 to 2002 reports showed primary resistance ranged from 4.7 to 12% for isoniazid, 0.7 to 5.9% for rifampin, 1 to 6% for ethambutol, and 4 to 11% for streptomycin. The overall rates of multidrug-resistant tuberculosis (MDRTB) among new cases and previously treated cases were 1 to 3% and 15 to 46%, respectively. The increasing burden of patients with MDRTB infection, the persistent high rate of mortality, the lack of nationwide surveillance system using the standard methodology to determine the trends and current status of resistance, and the inadequate current TB control infrastructure and training to accomplish the tasks required to implement the directly observed treatment short-course (DOTS) strategy are having a great impact on public health in Taiwan. Conclusions: High disease burden of TB and high resistance rates in MTB as well as inappropriateness of the current control infrastructure for TB services illustrate increasingly serious health problems from TB in Taiwan.

Original languageEnglish
Pages (from-to)77-85
Number of pages9
JournalJournal of Infection
Volume52
Issue number2
DOIs
Publication statusPublished - Feb 2006
Externally publishedYes

Fingerprint

Taiwan
Mycobacterium tuberculosis
Tuberculosis
Multidrug-Resistant Tuberculosis
Public Health
Annual Reports
Ethambutol
Mortality
Isoniazid
Health
Streptomycin
Rifampin
Centers for Disease Control and Prevention (U.S.)
Drug Resistance
MEDLINE
Population
Publications
Incidence
Infection

Keywords

  • Anti-microbial resistance
  • Disease burden
  • Mycobacterium tuberculosis
  • Taiwan

ASJC Scopus subject areas

  • Applied Microbiology and Biotechnology
  • Microbiology
  • Parasitology
  • Virology
  • Immunology and Allergy
  • Infectious Diseases

Cite this

Hsueh, P. R., Liu, Y. C., So, J., Liu, C. Y., Yang, P. C., & Luh, K. T. (2006). Mycobacterium tuberculosis in Taiwan. Journal of Infection, 52(2), 77-85. https://doi.org/10.1016/j.jinf.2005.08.008

Mycobacterium tuberculosis in Taiwan. / Hsueh, Po Ren; Liu, Yung Ching; So, Jen; Liu, Cheng Yi; Yang, Pan Chyr; Luh, Kwen Tay.

In: Journal of Infection, Vol. 52, No. 2, 02.2006, p. 77-85.

Research output: Contribution to journalArticle

Hsueh, PR, Liu, YC, So, J, Liu, CY, Yang, PC & Luh, KT 2006, 'Mycobacterium tuberculosis in Taiwan', Journal of Infection, vol. 52, no. 2, pp. 77-85. https://doi.org/10.1016/j.jinf.2005.08.008
Hsueh, Po Ren ; Liu, Yung Ching ; So, Jen ; Liu, Cheng Yi ; Yang, Pan Chyr ; Luh, Kwen Tay. / Mycobacterium tuberculosis in Taiwan. In: Journal of Infection. 2006 ; Vol. 52, No. 2. pp. 77-85.
@article{4fc72abe57134f56a697bef0a4f6a44d,
title = "Mycobacterium tuberculosis in Taiwan",
abstract = "Objective: The resurgence of tuberculosis (TB) and the emergence of drug resistance of Mycobacterium tuberculosis (MTB) isolates are of great impact on public health. Methods: Taiwanese data on disease burden of TB and anti-microbial resistance of MTB identified from Annual Reports of Centre for Disease Control, Department of Health, Taiwan and from peer-reviewed publications from MEDLINE (1995-2004). Results: In Taiwan in 2002, the incidence (per 100 000 population) of tuberculosis was 74.6 and it was higher in aborigines (289.8) and in people living in mountainous regions (256.0). The mortality rate of tuberculosis in Taiwan in 2002 was 5.68 per 100 000 population. Susceptibility data summarized from 1990 to 2002 reports showed primary resistance ranged from 4.7 to 12{\%} for isoniazid, 0.7 to 5.9{\%} for rifampin, 1 to 6{\%} for ethambutol, and 4 to 11{\%} for streptomycin. The overall rates of multidrug-resistant tuberculosis (MDRTB) among new cases and previously treated cases were 1 to 3{\%} and 15 to 46{\%}, respectively. The increasing burden of patients with MDRTB infection, the persistent high rate of mortality, the lack of nationwide surveillance system using the standard methodology to determine the trends and current status of resistance, and the inadequate current TB control infrastructure and training to accomplish the tasks required to implement the directly observed treatment short-course (DOTS) strategy are having a great impact on public health in Taiwan. Conclusions: High disease burden of TB and high resistance rates in MTB as well as inappropriateness of the current control infrastructure for TB services illustrate increasingly serious health problems from TB in Taiwan.",
keywords = "Anti-microbial resistance, Disease burden, Mycobacterium tuberculosis, Taiwan",
author = "Hsueh, {Po Ren} and Liu, {Yung Ching} and Jen So and Liu, {Cheng Yi} and Yang, {Pan Chyr} and Luh, {Kwen Tay}",
year = "2006",
month = "2",
doi = "10.1016/j.jinf.2005.08.008",
language = "English",
volume = "52",
pages = "77--85",
journal = "Journal of Infection",
issn = "0163-4453",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Mycobacterium tuberculosis in Taiwan

AU - Hsueh, Po Ren

AU - Liu, Yung Ching

AU - So, Jen

AU - Liu, Cheng Yi

AU - Yang, Pan Chyr

AU - Luh, Kwen Tay

PY - 2006/2

Y1 - 2006/2

N2 - Objective: The resurgence of tuberculosis (TB) and the emergence of drug resistance of Mycobacterium tuberculosis (MTB) isolates are of great impact on public health. Methods: Taiwanese data on disease burden of TB and anti-microbial resistance of MTB identified from Annual Reports of Centre for Disease Control, Department of Health, Taiwan and from peer-reviewed publications from MEDLINE (1995-2004). Results: In Taiwan in 2002, the incidence (per 100 000 population) of tuberculosis was 74.6 and it was higher in aborigines (289.8) and in people living in mountainous regions (256.0). The mortality rate of tuberculosis in Taiwan in 2002 was 5.68 per 100 000 population. Susceptibility data summarized from 1990 to 2002 reports showed primary resistance ranged from 4.7 to 12% for isoniazid, 0.7 to 5.9% for rifampin, 1 to 6% for ethambutol, and 4 to 11% for streptomycin. The overall rates of multidrug-resistant tuberculosis (MDRTB) among new cases and previously treated cases were 1 to 3% and 15 to 46%, respectively. The increasing burden of patients with MDRTB infection, the persistent high rate of mortality, the lack of nationwide surveillance system using the standard methodology to determine the trends and current status of resistance, and the inadequate current TB control infrastructure and training to accomplish the tasks required to implement the directly observed treatment short-course (DOTS) strategy are having a great impact on public health in Taiwan. Conclusions: High disease burden of TB and high resistance rates in MTB as well as inappropriateness of the current control infrastructure for TB services illustrate increasingly serious health problems from TB in Taiwan.

AB - Objective: The resurgence of tuberculosis (TB) and the emergence of drug resistance of Mycobacterium tuberculosis (MTB) isolates are of great impact on public health. Methods: Taiwanese data on disease burden of TB and anti-microbial resistance of MTB identified from Annual Reports of Centre for Disease Control, Department of Health, Taiwan and from peer-reviewed publications from MEDLINE (1995-2004). Results: In Taiwan in 2002, the incidence (per 100 000 population) of tuberculosis was 74.6 and it was higher in aborigines (289.8) and in people living in mountainous regions (256.0). The mortality rate of tuberculosis in Taiwan in 2002 was 5.68 per 100 000 population. Susceptibility data summarized from 1990 to 2002 reports showed primary resistance ranged from 4.7 to 12% for isoniazid, 0.7 to 5.9% for rifampin, 1 to 6% for ethambutol, and 4 to 11% for streptomycin. The overall rates of multidrug-resistant tuberculosis (MDRTB) among new cases and previously treated cases were 1 to 3% and 15 to 46%, respectively. The increasing burden of patients with MDRTB infection, the persistent high rate of mortality, the lack of nationwide surveillance system using the standard methodology to determine the trends and current status of resistance, and the inadequate current TB control infrastructure and training to accomplish the tasks required to implement the directly observed treatment short-course (DOTS) strategy are having a great impact on public health in Taiwan. Conclusions: High disease burden of TB and high resistance rates in MTB as well as inappropriateness of the current control infrastructure for TB services illustrate increasingly serious health problems from TB in Taiwan.

KW - Anti-microbial resistance

KW - Disease burden

KW - Mycobacterium tuberculosis

KW - Taiwan

UR - http://www.scopus.com/inward/record.url?scp=31344478261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=31344478261&partnerID=8YFLogxK

U2 - 10.1016/j.jinf.2005.08.008

DO - 10.1016/j.jinf.2005.08.008

M3 - Article

VL - 52

SP - 77

EP - 85

JO - Journal of Infection

JF - Journal of Infection

SN - 0163-4453

IS - 2

ER -